SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Innate Pharma Says PACIFIC-9 Phase 3 Readout Timing Moves to H1 2027

Innate Pharma said AstraZeneca updated the expected timing for PACIFIC-9 Phase 3 high-level data to the first half of 2027, from the second half of 2026.

IPHIPHA

Related stories